A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
12/2006
12/13/2006	CN1289466C Pharmaceutical compounds
12/13/2006	CN1289455C 2-(2,6-dichlorophenyl)-diarylimidazoles
12/13/2006	CN1289136C Preparation process of medicine for treating malignant tumor
12/13/2006	CN1289135C Preparation process of a kind of medicine
12/13/2006	CN1289127C Medicinal composition for treating tumour and its preparation method
12/13/2006	CN1289123C Medicine for treating late malignant tumour
12/13/2006	CN1289107C Fig buccal tablet and its preparing process
12/13/2006	CN1289104C Anticancer medicine and its preparation
12/13/2006	CN1289099C Process for preparation of Rhus verniciflus extract and anti-cancer composition containing same
12/13/2006	CN1289098C Vesicular stromatitis virus (VSV)
12/13/2006	CN1289089C Application of camptothecin derivative in drug preparing process for treating marrow originate leukemia
12/13/2006	CN1289088C Method for improving liposome enveloping rate of camptothecine or its derivatives
12/13/2006	CN1289080C Vegetable estrogen analogy composition capable of replacing estrogen and its application
12/13/2006	CN1289078C Novel paclitaxel emulsion for intravenous injection and its preparation method
12/13/2006	CN1289065C Vaccine containing saponin and sterol
12/12/2006	US7148349 Cyclic phosphate diesters of 1,3-propane-1-aryl diols and their use in preparing prodrugs
12/12/2006	US7148337 drug target and diagnostic marker for prostate cancer; host cells and expression vectors
12/12/2006	US7148331 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof
12/12/2006	US7148329 For modulating, in particular increasing or reducing, the immune response in an animal, such as a human or another mammal
12/12/2006	US7148326 Tumor antigen
12/12/2006	US7148252 Therapy or prphylaxis of primary brain cancer or a brain metastasis in a patient, comprising administering benzopyranones derivatives or their pharmaceutically acceptable salts
12/12/2006	US7148251 D-t-3',4'-ethylenedioxy-p4 derivatives; glucosyl ceramide inhibitors lower glycosphingolipid levels; anticarcinogenic, antitumor agents; angiogenesis inhibitors; tumor antigens
12/12/2006	US7148247 Substituted benzoxazoles as estrogenic agents
12/12/2006	US7148245 Skin disorders; aging resistance of skins; antiinflammatory agents; antiallergens; rheumatic diseases; cardiovascular disorders
12/12/2006	US7148240 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
12/12/2006	US7148239 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof
12/12/2006	US7148232 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
12/12/2006	US7148231 [6,7-Bis(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)amine hydrochloride polymorph
12/12/2006	US7148228 Heat Shock Protein 90 (HSP90); inflammatory, autoimmune, neurological, cardiac fibrogenetic and proliferative disorders and infections, tumors, leukemias, neoplasms, cancers, carcinomas, stroke, ischemia, metabolic diseases, and malignant disease
12/12/2006	US7148224 Pyrazinone derivatives
12/12/2006	US7148220 Tyrosine kinase enzyme inhibitors as growth factor receptors and useful as antiproliferation agents
12/12/2006	US7148218 Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors
12/12/2006	US7148216 Combinations of drugs for the treatment of neoplastic disorders
12/12/2006	US7148215 Prodrugs as antihistamines or anticarcinogenic agents
12/12/2006	US7148207 For therapy of cancer; quick release tablet of fludarabine phosphate in a defined composition of residual contaminants
12/12/2006	US7148204 An antisense compound 8 to 30 nucleobases in length targeted to a 3'-untranslated region, a stop codon region, a coding region, or a 5'-untranslated region of a nucleic acid molecule encoding human bcl-x gene or protein
12/12/2006	US7148202 Receptor-mediated gene delivery using bacteriophage vectors
12/12/2006	US7148201 Use of human plasma hyaluronidase in cancer treatment
12/12/2006	US7148200 Adenocarcinogenic agent
12/12/2006	US7148196 A peptide having the amino acid sequence proline, histidine, serine, arginine, and asparagine
12/12/2006	US7148195 Antitumor agents; hormone sensitive tumors; therapy for prostate gland or breast cancer
12/12/2006	US7148038 Immunotherapy; antiproliferative agent
12/12/2006	US7148002 Nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPase
12/12/2006	US7147855 GIPs, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein
12/12/2006	US7147849 Including compatible solute; enhancing effectiveness of protein containing active material; reducing cytotoxic activity
12/12/2006	US7147847 Lyophilised or sonicated Lactobacillus bacteria, grampositivie bacteria, gramnegative bacteria; antitumor agents, therapeutic treatment of autoimmune diseases, gastrointestinal disorders, nervodegenerative diseases
12/12/2006	US7147838 Competitive binding with bombesin; radiopharmaceuticals for treatment of neoplastic diseases
12/12/2006	CA2451725C Therapeutic combinations for the treatment of hormone deficiencies
12/12/2006	CA2347741C Thiazole-derivatives
12/12/2006	CA2278056C Gemcitabine derivatives
12/12/2006	CA2266081C Process for producing ecteinascidin compounds
12/12/2006	CA2263166C Reducing toxic effects of carboplatin using dithioethers
12/12/2006	CA2225284C Colchicine derivatives, the use thereof and formulations containing them
12/12/2006	CA2153336C Recombinant virus immunotherapy
12/12/2006	CA2146248C Process for preparing 10-desacetylbaccatine iii
12/07/2006	WO2006130532A2 Treatment of liver diseases in which iron plays a role in pathogenesis
12/07/2006	WO2006130458A2 Antibodies directed to cd20 and uses thereof
12/07/2006	WO2006130082A1 A peptide ligand to impair cancer cell migration
12/07/2006	WO2006129901A1 Anticancer agent, food and manufacturing method of anticancer agent and food
12/07/2006	WO2006129881A1 Prophylactic/therapeutic agent for bone/joint disease and screening method for the agent
12/07/2006	WO2006129842A1 Novel aminopyridine derivative having selective aurora-a inhibitory activity
12/07/2006	WO2006129784A1 INTERFERON-α REGULATOR
12/07/2006	WO2006129729A1 Marker for examination of tolerance of anti-cancer agent for pancreatic cancer, and adjunctive therapeutic agent for anti-cancer agent for pancreatic cancer
12/07/2006	WO2006129679A1 Spiropiperidine compound and medicinal use thereof
12/07/2006	WO2006129594A1 Method for producing nucleic acid-containing complex preparation
12/07/2006	WO2006129587A1 Pharmaceutical composition comprising pyrazolone derivative
12/07/2006	WO2006129583A1 Pyrazolone derivative
12/07/2006	WO2006129468A1 Process for preparation of granular oral composition using oligosaccharide solution
12/07/2006	WO2006129323A1 A composition to enhance the bioavailability of curcumin
12/07/2006	WO2006129168A2 Bicyclic derivatives for the treatment of abnormal cell growth
12/07/2006	WO2006129163A1 Combinations of erbb2 inhibitors with other therapeutic agents in the treatment of cancer
12/07/2006	WO2006129105A1 Fk 228 derivates as hdac inhibitors
12/07/2006	WO2006129064A1 Quinazolines and their use as aurora kinase inhibitors
12/07/2006	WO2006128909A1 Shp-2 inhibitors, pharmaceutical compositions comprising them and their use for treating phosphatase-mediated diseases
12/07/2006	WO2006128378A1 Use of ganoderic acid in treating tumour
12/07/2006	WO2006128293A1 Kinin b1 receptor peptide agonists and uses thereof
12/07/2006	WO2006128289A1 Use of brevinin-2r in the treatment of cancer
12/07/2006	WO2006128288A1 Formulation comprising farnesyl dibenzodiazepinone and a pharmaceutically acceptable surfactant
12/07/2006	WO2006128245A1 Targeting cells with altered microrna expression
12/07/2006	WO2006103494A3 Antiviral bifunctional molecules, methods of construction and methods of treating virus-induced cancer therewith
12/07/2006	WO2006102504A3 Combinations for the treatment of cancer comprising anti-egfr antibody and vegfr inhibitors
12/07/2006	WO2006092326A3 Mimetic peptides and the use thereof in the form of 20s, 26s and immunoproteasome inhibitors
12/07/2006	WO2006089231A3 Monoclonal antibodies against prostate specific membrane antigen (psma) lacking in fucosyl residues
12/07/2006	WO2006086978A3 Use of deuterated n-[2-(5-methoxy-1h-indol-3-yl)-ethyl]acetamides and the pharmaceutically acceptable salts thereof, and medicaments containing said compounds
12/07/2006	WO2006086822A9 A molecule and chimeric molecules thereof
12/07/2006	WO2006075094A3 Purine derivatives compositions containing the same and use thereof against cancer
12/07/2006	WO2006074399A3 Multispecific binding molecules comprising connecting peptides
12/07/2006	WO2006068760A3 Anti-inflammatory pyrazolopyrimidines
12/07/2006	WO2006053903A3 Low-molecular inhibitors of cytohesin-family guanine nucleotide exchange factors
12/07/2006	WO2005112919A8 Self-immolative linkers and drug conjugates
12/07/2006	WO2004024882A3 FLJ20647s AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE
12/07/2006	US20060277614 Mammal prolactin variants
12/07/2006	US20060276548 Inhibitors of endo-exonuclease activity for treating cancer
12/07/2006	US20060276524 2-(2,5-Dioxoimidazolidin-4-yl)-N-[2-(4'-fluoro-biphenyl-4-yl)-ethyl]-acetamide; asthma, chronic obstructive pulmonary disease, arthritis, atherosclerosis, restenosis; potent and highly selective inhibitors
12/07/2006	US20060276520 Rhodanine derivatives and pharmaceutical compositions containing them
12/07/2006	US20060276516 Inhibitors of kinases and treatment of diseases mediated by cytokines produced by p38
12/07/2006	US20060276497 Novel multicyclic compounds and the use thereof
12/07/2006	US20060276491 Therapeutic compounds
12/07/2006	US20060276488 (Anilino)(halo)pyrimidine derivatives or (anilino)(amino)pyrimidine derivatives; treating rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis.
12/07/2006	US20060276476 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid

1 ... 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 ... 2211